METHOD FOR THE TREATMENT OF MYASTHENIA GRAVIS

The disclosure relates to a method of treating or preventing Myasthenia Gravis (MG) in a human in need thereof using an anti-FcRn antibody or antigen binding fragment thereof. In particular, the method provides suitable dosage regimens for such treatment.

Saved in:
Bibliographic Details
Main Authors WEBSTER MANIS, Elizabeth, BROCK, Melissa Kaye, KIESSLING, Claus Peter, BYRNES, William James, GREVE, Bernhard Heinrich, LANGDON, Grant
Format Patent
LanguageEnglish
Published 28.05.2021
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The disclosure relates to a method of treating or preventing Myasthenia Gravis (MG) in a human in need thereof using an anti-FcRn antibody or antigen binding fragment thereof. In particular, the method provides suitable dosage regimens for such treatment.
Bibliography:Application Number: SG2021113801U